We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Image of Dr. Dominik Lock

Dr. Dominik Lock

R&D Group Leader – Early Drug Development, Miltenyi Biotec

Contact Us

Dr. Dominik Lock is leading the research group Early Drug Development at Miltenyi Biotec. His work evolves around non-viral gene engineering, process development as well as early pre-clinical development. His team solves challenges related to adoptive T cell therapies by inventing innovative technologies and novel manufacturing processes. By improving the potential of gene-engineered T cells, Dominik Lock strongly contributes to the company’s vision to ‘make cancer history’.